Next Article in Journal
COVID-19 Vaccination Modifies COVID-19-Related Headache Phenotype: Evidence from Case–Control Study on 309 Participants
Previous Article in Journal
Potential Regulatory Role of miR-15b, miR-99b, and miR-181a of the Shikonin-Induced MAPK/ERK Apoptotic Signaling Pathway in Renal Carcinoma
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biomedicines
Volume 13
Issue 12
10.3390/biomedicines13122899
biomedicines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Retraction of Biomedicines 2024, 12(5), 979.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Retraction

RETRACTED: Cheng et al. High PGC-1α Expression as a Poor Prognostic Indicator in Intracranial Glioma. Biomedicines 2024, 12, 979

by
Yu-Wen Cheng
1,2,
Jia-Hau Lee
3,
Chih-Hui Chang
4,
Tzu-Ting Tseng
4,
Chee-Yin Chai
2,5,6,
Ann-Shung Lieu
4,7,* and
Aij-Lie Kwan
2,4,7,8,*
1
Department of Neurosurgery, Kaohsiung Veterans General Hospital, Kaohsiung 807, Taiwan
2
Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan
3
National Institute of Cancer Research, National Health Research Institutes, Tainan 701, Taiwan
4
Division of Neurosurgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan
5
Department of Pathology, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan
6
Department of Pathology, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan
7
Department of Surgery, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan
8
Department of Neurosurgery, University of Virginia, Charlottesville, VA 23806, USA
*
Authors to whom correspondence should be addressed.
Biomedicines 2025, 13(12), 2899; https://doi.org/10.3390/biomedicines13122899
Submission received: 16 October 2025 / Accepted: 14 November 2025 / Published: 27 November 2025
(This article belongs to the Section Neurobiology and Clinical Neuroscience)
Versions Notes
The journal retracts the article “High PGC-1α Expression as a Poor Prognostic Indicator in Intracranial Glioma” [1] cited above.
Following publication, concerns were brought to the attention of the publisher regarding a partial overlap of images presented in this article [1].
Adhering to our complaint’s procedure, an investigation was conducted that confirmed a partial duplication within Figure 5, presenting different experimental conditions. While the authors cooperated with the Editorial Office during the investigation, they were unable to satisfactorily explain the similarities within Figure 5, nor provide raw material for the Editorial Board to review.
As a result, the Editorial Board has lost confidence in the reliability of the findings and has decided to retract this publication [1], as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30).
This retraction was approved by the Editor-in-Chief of the Biomedicines journal.
The authors disagree with this retraction.

Reference

  1. Cheng, Y.-W.; Lee, J.-H.; Chang, C.-H.; Tseng, T.-T.; Chai, C.-Y.; Lieu, A.-S.; Kwan, A.-L. RETRACTED: High PGC-1α Expression as a Poor Prognostic Indicator in Intracranial Glioma. Biomedicines 2024, 12, 979. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Cheng, Y.-W.; Lee, J.-H.; Chang, C.-H.; Tseng, T.-T.; Chai, C.-Y.; Lieu, A.-S.; Kwan, A.-L. RETRACTED: Cheng et al. High PGC-1α Expression as a Poor Prognostic Indicator in Intracranial Glioma. Biomedicines 2024, 12, 979. Biomedicines 2025, 13, 2899. https://doi.org/10.3390/biomedicines13122899

AMA Style

Cheng Y-W, Lee J-H, Chang C-H, Tseng T-T, Chai C-Y, Lieu A-S, Kwan A-L. RETRACTED: Cheng et al. High PGC-1α Expression as a Poor Prognostic Indicator in Intracranial Glioma. Biomedicines 2024, 12, 979. Biomedicines. 2025; 13(12):2899. https://doi.org/10.3390/biomedicines13122899

Chicago/Turabian Style

Cheng, Yu-Wen, Jia-Hau Lee, Chih-Hui Chang, Tzu-Ting Tseng, Chee-Yin Chai, Ann-Shung Lieu, and Aij-Lie Kwan. 2025. "RETRACTED: Cheng et al. High PGC-1α Expression as a Poor Prognostic Indicator in Intracranial Glioma. Biomedicines 2024, 12, 979" Biomedicines 13, no. 12: 2899. https://doi.org/10.3390/biomedicines13122899

APA Style

Cheng, Y.-W., Lee, J.-H., Chang, C.-H., Tseng, T.-T., Chai, C.-Y., Lieu, A.-S., & Kwan, A.-L. (2025). RETRACTED: Cheng et al. High PGC-1α Expression as a Poor Prognostic Indicator in Intracranial Glioma. Biomedicines 2024, 12, 979. Biomedicines, 13(12), 2899. https://doi.org/10.3390/biomedicines13122899

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop